跳至主要内容
临床试验/NCT03183440
NCT03183440Unknown不适用

A Multicenter Clinical Trial To Assess The Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children.

Nantes University Hospital6 个研究点 分布在 1 个国家目标入组 376 人开始时间: 2018年2月13日最近更新:
适应症

试验速览

阶段
不适用
入组人数
376
试验地点
6
主要终点
atopic dermatitis prevalence at M12

研究概览

简要总结

Allergies are increasing worldwide affecting 30-40% of the population. Among this, Atopic Dermatitis (AD) is the earliest and the most common manifestation of allergic diseases (prevalence 20%). Recent studies have shown that allergies were associated with a disruption of the gut microbial 'balance' suggesting that the use of nutritional intervention very early in life may restore an optimal pattern of microflora aiming at improving the host's health. So far, most human intervention studies have mainly focused on improving postnatal infant colonization. Our study will test the hypothesis that a maternal antenatal prebiotics (GOS/inulin) supplementation may be superior to placebo for AD prevention in high-risk children.

详细描述

Study design :

Inclusion visit at 20 weeks of gestation :

  • randomization
  • start of supplementation (GOS/inulin or placebo)

Phone call at 24 weeks of gestation :

  • checking tolerance
  • checking observance

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women with an eutocic pregnancy before 20 weeks of gestation
  • women with personal history of atopy diagnosed by a healthcare Professional
  • Women accepting a complete avoidance of dietary supplements containing prebiotics or probiotics during study supplementation
  • women accepting dermato-pediatric follow-up during the first year of life of the new-born (Phone calls at 24 weeks of gestation and 6 months of child and a consultation at 12 months of age)
  • non Tobacco user women
  • women over 18 years
  • women without history of severe gestational diabetes

排除标准

  • women not giving up on intake of dietary supplements containing prebiotics or probiotics during study supplementation
  • women refusing dermato-pediatric follow-up during the first year of the newborn
  • ongoing allergy and/or intolerance to cow's milk proteins
  • term >21 weeks of gestation

结局指标

主要结局

atopic dermatitis prevalence at M12

时间窗: at 12 months of age

prevalence will be evaluated according to UK party working group criteria

次要结局

  • food allergies prevalence at M12(at 12 months of age)
  • sensitization with the major allergens(at 12 months of age)
  • Quality of life of the child and his/her family(at 12 months of age)
  • atopic dermatitis prevalence at M6(at 6 months of age)
  • Tolerance of the prebiotics in mothers(from inclusion to delivery)
  • assessment of the Transepidermal Waterlos(at J1 and at 12 months of age)
  • atopic dermatitis severity(at 12 months of age)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验